Norsunate - Artesunate 200 mg Norsunate

Artesunate is an antimalarial medicine derived from artemisinin and is used primarily for the treatment of severe malaria. It acts rapidly against malaria parasites in the bloodstream by interfering with parasite survival and reducing parasite numbers. Artesunate is particularly important in the initial treatment of severe Plasmodium falciparum malaria and may also be used in other malaria infections according to clinical assessment and local treatment guidelines. Depending on the clinical situation and formulation, artesunate may be administered intravenously, intramuscularly, or orally in combination with other antimalarial medicines. Following initial treatment of severe malaria, an appropriate full course of an effective oral antimalarial regimen is generally required. Possible adverse effects may include nausea, vomiting, headache, dizziness, and, rarely, delayed hemolytic anemia or other blood-related complications. Artesunate should be administered under appropriate medical supervision and according to a qualified healthcare professional's prescription and guidance.